Sensus Healthcare, Inc. (SRTS)

NASDAQ: SRTS · IEX Real-Time Price · USD
8.02
-0.05 (-0.62%)
At close: Jun 24, 2022 4:00 PM
8.42
+0.40 (4.99%)
After-hours: Jun 24, 2022 7:02 PM EDT

Company Description

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.

The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services.

In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body.

Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Sensus Healthcare, Inc.
Sensus Healthcare Logo
Country United States
Founded 2010
IPO Date Jun 3, 2016
Industry Health Care Equipment & Supplies
Sector Health Care
Employees 37
CEO Joseph Sardano

Contact Details

Address:
851 Broken Sound Pkwy NW Ste 215
Boca Raton, Florida 33487-3635
United States
Phone 561 922 5808
Website sensushealthcare.com

Stock Details

Ticker Symbol SRTS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0001494891

Key Executives

Name Position
Joseph C. Sardano Co-Founder, Chairman and Chief Executive Officer
Michael J. Sardano President and General Counsel
Javier Rampolla Chief Financial Officer
Nicolas Soro Chief Operating Officer
Yonatan Vainer Chief Technology Officer
Benson Suen Vice President of International Sales
Dr. Mark S. Nestor Medical Director and Member of Medical Advisory Board
Dr. Clay Jefferies Cockerell Clinical Director and Member of Medical Advisory Board

Latest SEC Filings

Date Type Title
Jun 9, 2022 8-K Current report
May 12, 2022 10-Q Quarterly report [Sections 13 or 15(d)]
May 12, 2022 4 Statement of changes in beneficial ownership of securities
May 5, 2022 8-K Current report
Apr 29, 2022 DEF 14A Other definitive proxy statements
Mar 25, 2022 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2022 4 Statement of changes in beneficial ownership of securities
Mar 10, 2022 4 Statement of changes in beneficial ownership of securities
Mar 10, 2022 4 Statement of changes in beneficial ownership of securities
Mar 9, 2022 8-K Current report